Brief: Quince Therapeutics Adopts Limited Duration Stockholders Rights Plan
April 5 (Reuters) - Quince Therapeutics Inc QNCX.O :
* QUINCE THERAPEUTICS ADOPTS LIMITED DURATION STOCKHOLDERS
RIGHTS
PLAN
* QUINCE THERAPEUTICS- RIGHTS PLAN IS EFFECTIVE IMMEDIATELY
AND
HAS A ONE-YEAR DURATION, EXPIRING ON APRIL 5, 2024
* QUINCE THERAPEUTICS- ADOPTED RIGHTS PLAN FOLLOWING AN
UNSOLICITED ACQUISITION PROPOSAL AND ACCUMULATION OF QUINCE
SHARES BY CERTAIN INVESTORS
Source text for Eikon: ID:nBwYDgNga
Further company coverage: QNCX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges